Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?
The average brokerage recommendation (ABR) for Viking Therapeutics (VKTX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Zacks
More News
Viking Therapeutics, Inc. (VKTX) Declines More Than Market: Some Information for Investors
Viking Therapeutics, Inc. (VKTX) closed the most recent trading day at $32.13, moving 1.74% from the previous trading session.
Zacks
Axsome Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Key PointsAxsome Therapeutics has transitioned into a commercial-stage entity with rapidly growing revenue from its central nervous system treatments...
Nasdaq News: Markets
Analysts Have a $92 Target on Viking Therapeutics. Here's What Has to Go Right to Get There.
Key PointsViking Therapeutics is studying its weight-loss drug candidate in phase 3 trials...
Nasdaq News: Markets
Viking Therapeutics, Inc. (VKTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Viking Therapeutics, Inc. (VKTX) closed at $32.7 in the latest trading session, marking a -2.91% move from the prior day.
Zacks
Novo Nordisk's Semaglutide Meets Goal in Pediatric Obesity Study
NVO's semaglutide cuts BMI in children with obesity in phase III study, with 40.4% no longer classified as having obesity after 68 weeks.
Zacks
Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case.
Key PointsViking Therapeutics has significant upside potential based on Wall Street targets...
Nasdaq News: Markets
Why Is Mirum Pharmaceuticals (MIRM) Up 6.9% Since Last Earnings Report?
Mirum Pharmaceuticals (MIRM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Viking Therapeutics, Inc. (VKTX) Outperforms Broader Market: What You Need to Know
Viking Therapeutics, Inc. (VKTX) closed at $33.98 in the latest trading session, marking a +1.43% move from the prior day.
Zacks
3 Wall Street Analysts Think Viking Therapeutics Stock Will Roughly Triple Over the Next 12 Months. Here's Why I Think They're Wrong
Key PointsViking Therapeutics' shares could soar as it makes progress with its leading candidates...